SCHEMBL10003261

SCHEMBL10003261

Cc1nc2cc(I)ccc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 2/20 0.49
ALDH1A1 P00352 6/20 0.47
MAPT P10636 5/20 0.43
KDM4E B2RXH2 5/20 0.43
POLB P06746 4/20 0.43
HPGD P15428 4/20 0.43
RAB9A P51151 5/20 0.42
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HSP90AA1 P07900 1/20 0.42
ESR2 Q92731 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NOS1 P29475 1/20 0.41
GAA P10253 3/20 0.41
HSD17B10 Q99714 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29669436 1.00 TYMS (0.49) TYMSALDH1A1MAPTKDM4EPOLB
SCHEMBL8290000 0.84 ALDH1A1 (0.61) TYMSALDH1A1MAPTKDM4EPOLB
SCHEMBL25457211 0.79 RAB9A (0.53) ALDH1A1MAPTKDM4EPOLBHPGD
SCHEMBL12540 0.79 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EPOLBHPGD
SCHEMBL12052868 0.78 POLB (0.51) ALDH1A1MAPTKDM4EPOLBHPGD
SCHEMBL1925825 0.76 KDM4E (0.57) ALDH1A1MAPTKDM4EPOLBHPGD
SCHEMBL5787022 0.76 NOS1 (0.41) TYMSALDH1A1MAPTKDM4ERAB9A
SCHEMBL21983968 0.76 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EPOLBHPGD
SCHEMBL18745954 0.76 NOS1 (0.41) TYMSMAPTKDM4EPOLBRAB9A
SCHEMBL8982 0.76 TYMS (0.49) TYMSALDH1A1MAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138071-A1 SULFIDE GAS REMOVAL PROCESS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-05-21 US disclosed
US-20260014517-A1 HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-15 US disclosed
US-20260014197-A1 DRUG DELIVERY SYSTEM IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2026-01-15 US disclosed
US-20260014514-A1 METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-15 US disclosed
US-20260008009-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-08 US disclosed
US-20260002088-A1 PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-01 US disclosed
US-20250381514-A1 METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-12-18 US disclosed
US-12459862-B2 Cement paste composition KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-04 US disclosed
US-12427499-B2 Process for removing hydrogen sulfide from sour gases KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-09-30 US disclosed
US-12415726-B2 Process for simultaneous removal of hydrogen sulfide and heavy metals KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-09-16 US disclosed
CN-102936223-A Synthesis method and purification method of 5-iodo-2-methylbenzimidazole JIANGSU ZHONGDAN PHARMACEUTICAL RES CO LTD 2013-02-20 CN disclosed
CN-102936223-A Synthesis method and purification method of 5-iodo-2-methylbenzimidazole JIANGSU ZHONGDAN PHARMACEUTICAL RES CO LTD 2013-02-20 CN disclosed
US-20120208811-A1 Aminopyrazole Derivative F. HOFFMANN-LA ROCHE AG (CH) 2012-08-16 US disclosed
EP-2471786-A1 AMINOPYRAZOLE DERIVATIVE Chugai Seiyaku Kabushiki Kaisha (JP) 2012-07-04 EP disclosed
EP-2363399-A1 Labelled analogues of halobenzamides as radiopharmaceuticals INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2011-09-07 EP disclosed
US-20110183988-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. 2011-07-28 US disclosed
WO-2011079133-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-06-30 WO disclosed
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-03-11 US disclosed
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-03-11 US disclosed
WO-2008012782-A2 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008009-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION HMOX2, HMOX1, SCO2 TYMS 2340/4885ALDH1A1 3365/4885MAPT 2624/4885
US-20260014517-A1 HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION TST, SOD1, SAMM50 TYMS 3867/4885ALDH1A1 3428/4885MAPT 3068/4885
US-20120208811-A1 Aminopyrazole Derivative FGFR1, FGFR3, FGFR4 TYMS 4443/4885ALDH1A1 919/4885MAPT 4214/4885
US-20100061928-A1 LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS HRH3, H1-3, HRH4 TYMS 2573/4885ALDH1A1 794/4885MAPT 4014/4885
US-20260002088-A1 PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION SAMM50, SOD1, HNRNPH3 TYMS 2413/4885ALDH1A1 3149/4885MAPT 2806/4885
US-20260138071-A1 SULFIDE GAS REMOVAL PROCESS SAMM50, SRSF1, GTF2F1 TYMS 2523/4885ALDH1A1 4587/4885MAPT 2949/4885
US-20260014514-A1 METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR SOD1, MAFG, HMOX2 TYMS 2450/4885ALDH1A1 4774/4885MAPT 3303/4885
US-20260014197-A1 DRUG DELIVERY SYSTEM IPO8, SLC39A11, SLC2A8 TYMS 143/4885ALDH1A1 3703/4885MAPT 113/4885
US-20110183988-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR BRAF, ARAF, NRAS TYMS 3489/4885ALDH1A1 1224/4885MAPT 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.